Skip to content

Prime Medicine PRME Change in AR

Change in AR at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
-$39.8M-123%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
-$337K-117%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$0+100%
Regenxbio logo
RegenxbioRGNX
-$18.25M-1,061%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-$3.42M-106%
Wave Life Sciences logo
Wave Life SciencesWVE
-$1.28M+10.3%

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Operating income-$50.7M+3.3%
Net income-$49.1M+5.3%
EPS (diluted)-$0.28+30.0%

Balance sheet

See full
Cash & equivalents$77.8M-26.6%
Total debt$114.5M-5.5%
Total equity$76.7M-28.3%
Total assets$294.7M-10.2%

Cash flow

See full
Operating cash flow-$42.7M+12.6%
CapEx$214.0K-91.2%
Free cash flow-$42.9M+16.3%

Valuation

See full
Market cap$574.36M+111%
Enterprise value$611.08M+113%
P/S124×+6.3×

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-216.1%+1,519pp
Debt / equity1.5×+0.4×
Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prime Medicine's change in AR?
Prime Medicine (PRME) reported change in AR of $0 in Q1 2026.
How has Prime Medicine's change in AR changed year-over-year?
Prime Medicine's change in AR decreased by 100.0% year-over-year, from $17K to $0.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.